Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral

AI Analysis

Summary

Xilio Therapeutics granted non-qualified stock options to purchase 50,050 shares to two new employees under its 2022 Inducement Stock Incentive Plan, effective March 1, 2026, in compliance with Nasdaq Listing Rule 5635(c)(4).

Importance:2/10

Sentiment:

0.00

employee_compensationstock_optionsinducement_grantsnasdaq_compliancehiring

Related Companies

$XLO

Read the original article

Published by GlobeNewswire Pharma on March 2, 2026 12:30 PM

Read Original